why choose us

First received: August 08, 2023

Clinical Trial: Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

Study Status: Completed

Recruit Status: RECRUITING

Condition: CPVT1

Study Type: INTERVENTIONAL


Official Title: A Phase 2A, Investigator & Subject Blinded, Sponsor Unblinded, Placebo-Controlled, Clinical Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of CRD-4730 in Participants W

Brief Summary: This is a Phase 2, multicenter, double-blind, sponsor unblinded, placebo-controlled, single-dose clinical study of CRD-4730 to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of CRD-4730 when administered as single oral doses to participants with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).The study will have 2 cohorts in which participants with CPVT will participate in a 3-period, randomized 2-sequence study.Each participant will receive 2 different doses of…

Read more